This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kozel, T. R. Articles by Cazin, J. Search for Related Content PubMed PubMed Citation Articles by Kozel, T. R. Articles by Cazin, J., Jr.

 Previous Article  |  Next Article 

Infect Immun. 1971 February; 3(2): 287-294
Copyright © 1971 American Society for Microbiology. All Rights Reserved.

Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide

^a Department of Microbiology, University of Iowa, Iowa City, Iowa 52240

ABSTRACT

A weakly virulent nonencapsulated variant of Cryptococcus neoformans is described. The chemical structure and antigenicity of the soluble polysaccharides produced by the variant strain and a typical virulent strain were compared. The soluble polysaccharides produced by both strains were composed of the same constituent monosaccharides; however, the virulent strain produced a polysaccharide having a greater uronic acid content and a larger molecular size than that of the variant strain. Soluble polysaccharides from the two strains are not closely related immunologically. Soluble polysaccharide obtained from the virulent strain did not affect persistence of the variant strain in mice.

¹ NDEA Title IV Predoctoral Fellow.

This article has been cited by other articles:

• McFadden, D. C., De Jesus, M., Casadevall, A. (2006). The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction. J. Biol. Chem. 281: 1868-1875 [Abstract] [Full Text]  
• Ren, P., Rossettini, A., Chaturvedi, V., Hanes, S. D. (2005). The Ess1 prolyl isomerase is dispensable for growth but required for virulence in Cryptococcus neoformans. Microbiology 151: 1593-1605 [Abstract] [Full Text]  
• Syme, R. M., Spurrell, J. C. L., Amankwah, E. K., Green, F. H. Y., Mody, C. H. (2002). Primary Dendritic Cells Phagocytose Cryptococcus neoformans via Mannose Receptors and Fc{gamma} Receptor II for Presentation to T Lymphocytes. Infect. Immun. 70: 5972-5981 [Abstract] [Full Text]  
• Wilder, J. A., Olson, G. K., Chang, Y. C., Kwon-Chung, K. J., Lipscomb, M. F. (2002). Complementation of a Capsule Deficient Cryptococcus neoformans with Cap64 Restores Virulence in a Murine Lung Infection. Am. J. Respir. Cell Mol. Bio. 26: 306-314 [Abstract] [Full Text]  
• D'Souza, C. A., Alspaugh, J. A., Yue, C., Harashima, T., Cox, G. M., Perfect, J. R., Heitman, J. (2001). Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformans. Mol. Cell. Biol. 21: 3179-3191 [Abstract] [Full Text]  
• Feldmesser, M., Kress, Y., Casadevall, A. (2001). Intracellular Crystal Formation as a Mechanism of Cytotoxicity in Murine Pulmonary Cryptococcus neoformans Infection. Infect. Immun. 69: 2723-2727 [Abstract] [Full Text]  
• Furukawa, K., Sasaki, H., Pollard, R. B., Suzuki, F. (2000). Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. J Antimicrob Chemother 46: 443-450 [Abstract] [Full Text]  
• Syme, R. M., Bruno, T. F., Kozel, T. R., Mody, C. H. (1999). The Capsule of Cryptococcus neoformans Reduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody. Infect. Immun. 67: 4620-4627 [Abstract] [Full Text]  
• Doering, T. L. (1999). A Unique alpha -1,3 Mannosyltransferase of the Pathogenic Fungus Cryptococcus neoformans. J. Bacteriol. 181: 5482-5488 [Abstract] [Full Text]